Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""NEUROTRANSMITTER uptake inhibitors"" wg kryterium: Temat


Tytuł:
Tissue and Circulating MicroRNAs 378 and 142 as Biomarkers of Obesity and Its Treatment Response.
Autorzy:
Matveev, Georgy A. (AUTHOR)
Khromova, Natalya V. (AUTHOR)
Zasypkin, German G. (AUTHOR)
Kononova, Yulia A. (AUTHOR)
Vasilyeva, Elena Yu. (AUTHOR)
Babenko, Alina Yu. (AUTHOR)
Shlyakhto, Evgeny V. (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13426. 18p.
Czasopismo naukowe
Tytuł:
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Autorzy:
Feduccia AA; Psychedelic.Support, Project New Day, Santa Cruz, CA, USA. .
Jerome L; MAPS Public Benefit Corporation, Santa Cruz, CA, USA.
Mithoefer MC; MAPS Public Benefit Corporation, Santa Cruz, CA, USA.; Medical University of South Carolina, Charleston, SC, USA.
Holland J; Private Practice, New York, NY, USA.
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2021 Feb; Vol. 238 (2), pp. 581-588. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Tapering*
Antidepressive Agents/*administration & dosage
N-Methyl-3,4-methylenedioxyamphetamine/*administration & dosage
Neurotransmitter Uptake Inhibitors/*administration & dosage
Psychotherapy/*methods
Stress Disorders, Post-Traumatic/*drug therapy
Adult ; Antidepressive Agents/therapeutic use ; Clinical Trials, Phase II as Topic ; Combined Modality Therapy ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Neurotransmitter Uptake Inhibitors/therapeutic use ; Psychiatric Status Rating Scales ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Electrophysiology and Behavioral Assessment of the New Molecule SMe1EC2M3 as a Representative of the Future Class of Triple Reuptake Inhibitors.
Autorzy:
Koprdova R; Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
Csatlosova K; Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
Durisova B; Institute of Molecular Physiology and Genetics, Center of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 840 05 Bratislava, Slovakia.
Bogi E; Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
Majekova M; Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
Dremencov E; Institute of Molecular Physiology and Genetics, Center of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 840 05 Bratislava, Slovakia.; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia.
Mach M; Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2019 Nov 20; Vol. 24 (23). Date of Electronic Publication: 2019 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Antidepressive Agents*/chemistry
Antidepressive Agents*/pharmacokinetics
Antidepressive Agents*/pharmacology
Neurotransmitter Uptake Inhibitors*/chemistry
Neurotransmitter Uptake Inhibitors*/pharmacokinetics
Neurotransmitter Uptake Inhibitors*/pharmacology
Electrophysiological Phenomena/*drug effects
Neurons/*metabolism
Synaptic Transmission/*drug effects
Animals ; Male ; Rats ; Rats, Wistar
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
The Art of Communicating Risk and Benefit to Promote Shared Decision‐Making, Informed by Behavioral Economic Principles.
Autorzy:
Curtis, Jeffrey R.
Fraenkel, Liana
Pokaż więcej
Temat:
TUMOR risk factors
ANTI-inflammatory agents
RISK assessment
HEALTH attitudes
RHEUMATOID arthritis
MAJOR adverse cardiovascular events
HEALTH
DECISION making
INFORMATION resources
ANTIRHEUMATIC agents
JANUS kinases
PATIENT-professional relations
COMMUNICATION
QUALITY assurance
NEUROTRANSMITTER uptake inhibitors
DISCLOSURE
DISEASE risk factors
Źródło:
Arthritis & Rheumatology; Apr2024, Vol. 76 Issue 4, p493-496, 4p
Czasopismo naukowe
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
Biologics in Focus: A Comprehensive Review of the Current Biological Therapies for Ulcerative Colitis in the United Arab Emirates (UAE).
Autorzy:
El-Sayed, Ahmed
Oztumer, Ceyhun
Richards, Camellia
Salim, Omar-Adam
Sivakumar, Mathuri
Alrubaiy, Laith
Pokaż więcej
Temat:
BIOTHERAPY
PATIENT safety
COST effectiveness
ULCERATIVE colitis
TREATMENT effectiveness
JANUS kinases
INFLIXIMAB
NEUROTRANSMITTER uptake inhibitors
CYTOKINES
BIOSIMILARS
TUMOR necrosis factors
INTERLEUKINS
SPONTANEOUS cancer regression
EVALUATION
Źródło:
Gastrointestinal Disorders; Mar2024, Vol. 6 Issue 1, p241-256, 16p
Terminy geograficzne:
UNITED Arab Emirates
Czasopismo naukowe
Tytuł:
Treatment Adherence and Adherence Patterns of Tofacitinib and Self‐Injectable TNFi Use in People with Rheumatoid Arthritis.
Autorzy:
Michaud, Kaleb
Pedro, Sofia
Tousset, Eric
Schumacher, Rebecca
Agarwal, Ekta
Vrijens, Bernard
Pokaż więcej
Temat:
CLINICAL drug trials
ANTI-inflammatory agents
FISHER exact test
JANUS kinases
RHEUMATOID arthritis
QUESTIONNAIRES
DESCRIPTIVE statistics
CHI-squared test
KAPLAN-Meier estimator
RESEARCH funding
PATIENT compliance
NEUROTRANSMITTER uptake inhibitors
DEMOGRAPHY
Źródło:
ACR Open Rheumatology; Feb2024, Vol. 6 Issue 2, p72-80, 9p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies